| Dr Piero Capecci, MD | |
|
800 N 1st St, Springfield, IL 62702-3719 | |
| (217) 528-7541 | |
| Not Available |
| Full Name | Dr Piero Capecci |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | 800 N 1st St, Springfield, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154321222 | NPI | - | NPPES |
| 36109573 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 36109573 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Taylorville Memorial Hospital | Taylorville, IL | Hospital |
| St Johns Hospital | Springfield, IL | Hospital |
| Memorial Medical Center | Springfield, IL | Hospital |
| Abraham Lincoln Memorial Hospital | Lincoln, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Springfield Clinic Llp | 0547166076 | 669 |
News Archive
American Physicians Capital, Inc. today announced it has completed its October 2, 2009 $10 million authorization under its 10b5-1 stock repurchase plan. The Company has commenced its $20 million authorization under its 10b5-1 plan approved by its Board of Directors on December 3, 2009.
AMAG Pharmaceuticals, Inc. today announced that new data from two pivotal phase III clinical trials were presented at the American Society of Hematology's (ASH) annual meeting in Atlanta, Georgia.
Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/833,323, which covers the use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate. Once issued, this patent will expire in February 2025.
EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 40,229,886 units.
› Verified 4 days ago
| Entity Name | Springfield Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780638478 PECOS PAC ID: 0547166076 Enrollment ID: O20040331000826 |
News Archive
American Physicians Capital, Inc. today announced it has completed its October 2, 2009 $10 million authorization under its 10b5-1 stock repurchase plan. The Company has commenced its $20 million authorization under its 10b5-1 plan approved by its Board of Directors on December 3, 2009.
AMAG Pharmaceuticals, Inc. today announced that new data from two pivotal phase III clinical trials were presented at the American Society of Hematology's (ASH) annual meeting in Atlanta, Georgia.
Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/833,323, which covers the use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate. Once issued, this patent will expire in February 2025.
EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 40,229,886 units.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Piero Capecci, MD Po Box 19248, Springfield, IL 62794-9248 Ph: (217) 528-7541 | Dr Piero Capecci, MD 800 N 1st St, Springfield, IL 62702-3719 Ph: (217) 528-7541 |
News Archive
American Physicians Capital, Inc. today announced it has completed its October 2, 2009 $10 million authorization under its 10b5-1 stock repurchase plan. The Company has commenced its $20 million authorization under its 10b5-1 plan approved by its Board of Directors on December 3, 2009.
AMAG Pharmaceuticals, Inc. today announced that new data from two pivotal phase III clinical trials were presented at the American Society of Hematology's (ASH) annual meeting in Atlanta, Georgia.
Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/833,323, which covers the use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate. Once issued, this patent will expire in February 2025.
EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 40,229,886 units.
› Verified 4 days ago
Elliot M Johns, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 301 N 8th St Ste 3a158, Springfield, IL 62701 Phone: 317-697-6136 | |
Dr. Austin Michael Beason, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 701 N 1st St, Springfield, IL 62702 Phone: 217-545-8000 | |
Kathleen Kay, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 701 N 1st St, Springfield, IL 62702 Phone: 217-545-8000 Fax: 217-545-1159 | |
John R Fisk, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 N 8th St, Springfield, IL 62701 Phone: 217-545-7500 Fax: 217-545-7305 | |
Jasmin L Mcginty, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 N 8th St, Ste Pav3b, Springfield, IL 62701 Phone: 217-545-7500 Fax: 217-545-7305 | |
Christopher Evan Bejcek, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 701 N 1st St, Springfield, IL 62702 Phone: 217-545-8000 Fax: 217-545-1159 |